Clinical Trial Update: Cixutumumab in Treating Patients With Metastatic Melanoma of the Eye [Phase 2]

View source ↗

Summary

Phase 2 trial update for cixutumumab in metastatic intraocular melanoma (ciliary body/choroid, iris) completed with posted results in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choroidal Melanoma
• Ciliary Body Melanoma
• Intraocular Melanoma
• Iris Melanoma

Drugs mentioned

• Cixutumumab (Cixutumumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma, Small Size | Phase 2 | Status: COMPLETED | Results posted: 2015-07-20